← SynDRA
ELDECALCITOL
SynDRA canonical compound SYN0039704 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | VDR |
|---|
| Mechanism of action | bone formation stimulant |
|---|
All known targets
Mechanisms of action (all sources)
- VDR AGONIST
- Vitamin D receptor agonist
- bone formation stimulant
Drug classes
- Bone Density Conservation Agents
Cross-references
Synonyms
- ED-71
- Ed-71
- Edirol
- ED 71
- 2-(3-Hydroxypropoxy)calcitriol
- I2JP8UE90H
- 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3
- 2-(3-Hydroxypropoxy)-1,25-dihydroxyvitamin D3
- 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)cholecalciferol
- CHEBI:73927
- eldecalcitolum
- RefChem:590686
- DTXCID401515581
- Eldecalcitol [INN:JAN]
- UNII-I2JP8UE90H
- Eldecalcitol [INN]
- 2beta-(3-hydroxypropoxy)calcitriol
- HY-A0020
- Edirol (TN)
- Eldecalcitol (Standard)
- Eldecalcitol (JAN/INN)
- ELDECALCITOL [MI]
- ELDECALCITOL [JAN]
- ELDECALCITOL [MART.]
- ELDECALCITOL [WHO-DD]
- GTPL2783
- orb1707340
- SCHEMBL5457151
- HY-A0020R
- EX-A5554
- CT-081
- LMST03020477
- MFCD25977156
- AKOS025312299
- CS-0363
- AC-26354
- MS-29124
- NS00069600
Look up ELDECALCITOL in the interactive SynDRA portal →